Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D3.8/L8: medical device reports filed with FDA

2,383 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,383
device reports naming the brand
0% of all MAUDE reports · about 337 a year
250
reports, 12 months to August 2026
344 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,383 reports that name the brand "XiVE S plus Impl D3.8/L8" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

250 reports arrived in the 12 months to August 2026, down 27% from 344 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (37.3%), osseointegration problem (31.6%) and loss of osseointegration (28.1%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02754Sep 2021: 20Oct 2021: 36Nov 2021: 30Dec 2021: 372022Jan 2022: 40Feb 2022: 51Mar 2022: 22Apr 2022: 33May 2022: 46Jun 2022: 50Jul 2022: 37Aug 2022: 38Sep 2022: 28Oct 2022: 36Nov 2022: 49Dec 2022: 462023Jan 2023: 40Feb 2023: 37Mar 2023: 37Apr 2023: 38May 2023: 54Jun 2023: 35Jul 2023: 32Aug 2023: 21Sep 2023: 30Oct 2023: 22Nov 2023: 23Dec 2023: 342024Jan 2024: 33Feb 2024: 26Mar 2024: 19Apr 2024: 36May 2024: 30Jun 2024: 31Jul 2024: 32Aug 2024: 44Sep 2024: 30Oct 2024: 47Nov 2024: 43Dec 2024: 152025Jan 2025: 18Feb 2025: 27Mar 2025: 51Apr 2025: 9May 2025: 26Jun 2025: 15Jul 2025: 37Aug 2025: 26Sep 2025: 40Oct 2025: 24Nov 2025: 17Dec 2025: 242026Jan 2026: 31Feb 2026: 14Mar 2026: 11Apr 2026: 27May 2026: 17Jun 2026: 20Jul 2026: 13Aug 2026: 12

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03116222019: 3720192021: 62220212022: 47620222023: 40320232024: 38620242025: 31420252026: 1452026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,383
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,383
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate88937.3%62.8%
Osseointegration problem75331.6%7.7%
Loss of osseointegration67028.1%22.4%
Fracturea broken bone692.9%1.6%
Loosening of implant not related to bone-ingrowth30.1%0.1%
Malposition of device20.1%0.1%
Damaged thread10%0%
Material deformation10%0.1%
Separation failure10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,383100%
Inflammationinflammation24710.4%
Osteolysis1516.3%
Pocket erosion1064.4%
Tooth loss30.1%
Implant pain20.1%
Inadequate osseointegration20.1%
Laceration(s)20.1%
Abscessa collection of pus10%
Foreign body in patientpart of a device left in the patient10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D3.8/L8Product code DZEAll MAUDE reports
Reports2,3833,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D3.8/L8 reports

How many FDA reports name XiVE S plus Impl D3.8/L8?

2,383 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 250 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (37.3%), osseointegration problem (31.6%), loss of osseointegration (28.1%), fracture (2.9%) and loosening of implant not related to bone-ingrowth (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D3.8/L8 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.